| __timestamp | Evotec SE | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 13673000 |
| Thursday, January 1, 2015 | 18343000 | 14358000 |
| Friday, January 1, 2016 | 18108000 | 12203000 |
| Sunday, January 1, 2017 | 17614000 | 18125000 |
| Monday, January 1, 2018 | 35619000 | 17071000 |
| Tuesday, January 1, 2019 | 58432000 | 20018000 |
| Wednesday, January 1, 2020 | 63945000 | 32788000 |
| Friday, January 1, 2021 | 72200000 | 44966000 |
| Saturday, January 1, 2022 | 76642000 | 311681000 |
| Sunday, January 1, 2023 | 57519000 | 77707000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology and pharmaceuticals, innovation is the key to staying ahead. Lantheus Holdings, Inc. and Evotec SE, two prominent players in the industry, have demonstrated varying commitments to research and development (R&D) over the past decade.
From 2014 to 2023, Evotec SE consistently increased its R&D spending, peaking in 2022 with a 518% increase from its 2014 levels. Meanwhile, Lantheus Holdings, Inc. showed a dramatic surge in 2022, with R&D expenses skyrocketing by over 2,200% compared to 2014. This significant investment underscores Lantheus's strategic pivot towards innovation.
While Evotec SE maintained a steady growth trajectory, Lantheus's recent spike suggests a newfound emphasis on R&D, potentially reshaping its competitive edge. As the industry continues to prioritize innovation, these trends offer valuable insights into the strategic priorities of these companies.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
Lantheus Holdings, Inc. and Evotec SE: A Detailed Gross Profit Analysis
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?